Source - SMW
Faron Pharmaceuticals plans to host an R&D Day on  21 Feb at Panmure Gordon's offices, One New Change, London, EC4M 9AF. 

The event will provide an opportunity to hear about the company, its R&D strategy and pipeline developments, with a focus on Clevegen, Faron's second wholly-owned pipeline product approaching the start of phase I/II development in 2018.